Compare BIO & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | PIPR |
|---|---|---|
| Founded | 1952 | 1895 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.8B |
| IPO Year | N/A | 2003 |
| Metric | BIO | PIPR |
|---|---|---|
| Price | $262.97 | $293.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $358.50 | ★ $365.50 |
| AVG Volume (30 Days) | ★ 235.7K | 175.1K |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | N/A | ★ 54.49 |
| EPS | N/A | ★ 15.82 |
| Revenue | N/A | ★ $1,904,217,000.00 |
| Revenue This Year | $2.74 | $13.14 |
| Revenue Next Year | $3.05 | $13.08 |
| P/E Ratio | ★ $9.72 | $18.62 |
| Revenue Growth | N/A | ★ 24.33 |
| 52 Week Low | $211.43 | $202.91 |
| 52 Week High | $343.12 | $380.26 |
| Indicator | BIO | PIPR |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 42.30 |
| Support Level | $239.33 | $276.37 |
| Resistance Level | $289.61 | $341.25 |
| Average True Range (ATR) | 7.46 | 8.68 |
| MACD | 0.44 | 2.13 |
| Stochastic Oscillator | 19.99 | 57.50 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.